Bay Area Biotech Company Develops Promising New Class Of Drug To Treat COVID-19 PatientsA Bay Area biotechnology company has discovered a new way to make a COVID-19 treatment by producing an entirely new class of drugs. Soon, the invention will be tested in human clinical trials.
Ready For Primetime Or False Hope? Richmond's ARCpoint Labs Providing COVID-19 Antibody TestsIt’s being touted as the newest weapon in the battle against the deadly coronavirus: an antibody test that promises to tell you if you’ve been infected and developed antibodies.
Stanford Study On MLB COVID-19 Antibodies May Help Settle Debate On Infection Rate Of VirusAntibody test studies have also been conducted in Los Angeles, Miami and New York. But the Stanford-Major League Baseball study is the first to look at infection rates across the entire country.
UC Berkeley, UCSF Researchers Post Preliminary Results Of Joint COVID-19 Antibody Test Kit StudyResearchers at UC Berkeley and UCSF launched a joint study of antibody test kits to examine potential immunity, temporary or otherwise, to COVID-19. Preliminary results can be found at covidtestingproject.org.
WHO: No Evidence That Antibodies Protect From Future COVID-19 InfectionIn a newly published scientific brief, the World Health Organization said that there is currently no evidence that people who have recovered from COVID-19 and have antibodies are protected from getting a second infection.
Coronavirus Update: Stanford Study Suggests COVID-19 Infections Much More Widespread Than ReportedNew findings from Stanford University researchers study suggests coronavirus infections are much more widespread than what health authorities have determined.